How have CPMD shares performed in 2024?

CannaPharmaRX's stock was trading at $0.0017 at the beginning of the year. Since then, CPMD shares have increased by 488.2% and is now trading at $0.01. View the best growth stocks for 2024 here .

Are investors shorting CannaPharmaRX?

CannaPharmaRX saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,900 shares, an increase of 26.7% from the March 15th total of 1,500 shares. Based on an average daily trading volume, of 3,469,700 shares, the days-to-cover ratio is currently 0.0 days. View CannaPharmaRX's Short Interest .

What other stocks do shareholders of CannaPharmaRX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CannaPharmaRX investors own include Curaleaf (CURLF) , Aimmune Therapeutics (AIMT) , Refined Metals (CADMF) , KushCo (KSHB) , Dynavax Technologies (DVAX) , GW Pharmaceuticals (GWPH) , Organigram (OGI) and AIM ImmunoTech (AIM) .

How do I buy shares of CannaPharmaRX?

Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CPMD

CannaPharmaRX (CPMD) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free CPMD Stock Alerts

$0.01

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.01
▼
$0.01
50-Day Range: $0.00
▼
$0.02
52-Week Range: $0.00
▼
$0.03

Volume: N/A
Average Volume: 980,252 shs
Market Capitalization: $6.61 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get CannaPharmaRX alerts:

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About CannaPharmaRX Stock (OTCMKTS:CPMD)

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

CPMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CPMD Stock News Headlines

March 14, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of Product

March 12, 2024 | finanznachrichten.de

CannaPharmaRx, Inc.: CannaPharmaRx Completes First Harvests

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 7, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx to Hold Investor Conference Call

March 5, 2024 | msn.com

Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America

March 5, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas

February 23, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration

February 16, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 16, 2024 | finance.yahoo.com

CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek

February 15, 2024 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx CEO Provides Annual Update Message

February 15, 2024 | stockhouse.com

CannaPharmaRx CEO Provides Annual Update Message

September 10, 2023 | finance.yahoo.com

CannaPharmaRX, Inc. (CPMD) Stock Historical Prices & Data - Yahoo Finance

August 25, 2023 | finanznachrichten.de

Cannapharmarx, Inc.: CannaPharmaRx Expands Board of Directors

August 25, 2023 | finance.yahoo.com

CannaPharmaRx Expands Board of Directors

June 23, 2023 | finance.yahoo.com

CannaPharmaRx Appoints Dean Medwid as New CEO

April 19, 2023 | finance.yahoo.com

CannaPharmaRx Signs Agreement with Nasha Genetics

April 4, 2023 | uk.finance.yahoo.com

CannaPharmaRX, Inc. (CPMD) stock historical prices & data – Yahoo Finance

March 30, 2023 | finance.yahoo.com

CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis

March 21, 2023 | finance.yahoo.com

CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website

February 21, 2023 | finance.yahoo.com

CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company

February 1, 2023 | finance.yahoo.com

CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock

January 30, 2023 | finance.yahoo.com

CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023

January 11, 2023 | finance.yahoo.com

CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected

December 22, 2022 | finance.yahoo.com

Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond

December 21, 2022 | finance.yahoo.com

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million

December 21, 2022 | finance.yahoo.com

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million

See More Headlines

Receive CPMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:CPMD
CUSIP: N/A
CIK: 1081938
Web: www.cannapharmarx.com
Phone: (949) 652-6838
Fax: 720-875-1905
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.03)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,530,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -141.66%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.07) per share
Price / Book: -0.14

Miscellaneous

Outstanding Shares: 660,630,000
Free Float: 652,236,000
Market Cap: $6.61 million
Optionable: Not Optionable
Beta: 2.12

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Dominick Colvin (Age 55)
President & Director
Comp: $94.65k
Mr. Dean P. Medwid (Age 56)
Chief Executive Officer
Mr. Oliver W. Foeste C.A. (Age 48)
CPA, Chief Financial Officer

Key Competitors

View All Competitors

CPMD Stock Analysis - Frequently Asked Questions

How have CPMD shares performed in 2024?: CannaPharmaRX's stock was trading at $0.0017 at the beginning of the year. Since then, CPMD shares have increased by 488.2% and is now trading at $0.01.
View the best growth stocks for 2024 here.
Are investors shorting CannaPharmaRX?: CannaPharmaRX saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,900 shares, an increase of 26.7% from the March 15th total of 1,500 shares. Based on an average daily trading volume, of 3,469,700 shares, the days-to-cover ratio is currently 0.0 days.
View CannaPharmaRX's Short Interest.
What other stocks do shareholders of CannaPharmaRX own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CannaPharmaRX investors own include Curaleaf (CURLF), Aimmune Therapeutics (AIMT), Refined Metals (CADMF), KushCo (KSHB), Dynavax Technologies (DVAX), GW Pharmaceuticals (GWPH), Organigram (OGI) and AIM ImmunoTech (AIM).
How do I buy shares of CannaPharmaRX?: Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CPMD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial